Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/6245
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMoss, J.-
dc.contributor.authorMarley, J.-
dc.contributor.authorWing, L.-
dc.date.issued1995-
dc.identifier.citationPharmacoepidemiology and Drug Safety, 1995; 4(Suppl.1):12--
dc.identifier.issn1053-8569-
dc.identifier.issn1099-1557-
dc.identifier.urihttp://hdl.handle.net/2440/6245-
dc.descriptionSee pg.12 of pdf Abstract from: 11th International Conference on Pharmacoepidemiology, Montréal, Canada, 27–30 August 1995 Article first published online: 31 JAN 2006-
dc.description.statementofresponsibilityJohn R. Moss, John Marley, Lindon Wing and High Blood Pressure Research Council of Australia-
dc.language.isoen-
dc.publisherJohn Wiley & Sons-
dc.rights© 1995 John Wiley & Sons, Ltd-
dc.source.urihttp://dx.doi.org/10.1002/pds.2630040702-
dc.subjecthypertension-
dc.subjecteconomics-
dc.subjectoutcome study-
dc.subjectdiuretic-
dc.subjectACE inhibitor-
dc.titleQuality of life measurement in the second Australian National Blood Pressure Study (ANBPS2)-
dc.typeJournal article-
dc.identifier.doi10.1002/pds.2630040702-
pubs.publication-statusPublished-
dc.identifier.orcidMoss, J. [0000-0003-4216-1761]-
Appears in Collections:Aurora harvest 5
General Practice publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.